Children’s Medical Center Researchers Tie Gene To Pediatric Cancer, Hope To Spur New Treatments
Dallas researchers have pinpointed a gene that fuels the development of several pediatric cancers, a finding that could serve as an impetus for pharmaceutical companies to develop new cancer treatments that help without using chemotherapy. A team at the Children’s Medical Center Research Institute at UT Southwesternpublished a white paper in the journal Cancer Cell on Monday tying an overactive gene that typically regulates puberty timing, glucose, and metabolism in children with the development of cancers like neuroblastoma and hepatoblastoma, which accounts for nearly 80 percent of pediatric liver tumors. The gene, named Lin28b, has... Read More
